Skip to main content
OpenTrials
Completed

NCT Number: NCT05995652

Can Shear Wave Elastography Predict the Success of ESWL: a Prospective Study

Can Shear Wave Elastography predict the success of Shock-Wave Lithotripsy used in renal stones treatment ? A prospective study

Completed

Looking for future studies?

Notify Me

Key information

About this study

Extracorporeal shock-wave lithotripsy (ESWL) is the noninvasive treatment method that is recommended as the first choice in the treatment of small and medium sized renal stones and proximal ureteral stones.

This study is a trial to determine the predictive role of shear wave elastography in the success of ESWL management of kidney stones.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients more than 18 years
  • With single radiopaque renal stone
  • Ranging in size from (1-1,5 cm) for ESWL.

Exclusion criteria

  • Any urological abnormal anatomy
  • Lower calyceal stone more than 1cm
  • Impaired renal functions
  • Uncorrected coagulopathy.
  • Active UTI Pregnancy Single kidney Multiple stones

Treatment and study plan

Elastography

Procedure

elastography

Primary outcomes

  1. stone free rate

    Time frame: 1 month

    post ESWL

Sponsors and collaborators

Lead sponsor

Abdelrahim Elsherbiny

Other

Registry information

Official study title

Can Shear Wave Elastography Predict the Success of Shock-Wave Lithotripsy Used in Renal Stones Treatment: a Prospective Study

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 16, 2023
Registry last updated
Feb 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.